Skip to main content

Table 2 Clinicopathological characteristics of the 10 PDTC and 27 ATC included in the study

From: Comprehensive gene expression analysis for exploring the association between glucose metabolism and differentiation of thyroid cancer

Variables

PDTC/ATC

No. of available data

Gender (M:F)

10: 27

37

Age (years, mean ± SD)

69 ± 13.74 (27–87)

37

Histology

 Papillary / Follicular / Tall cell / Other

14 / 5 / 5 / 5

29

 BRAFV600E (Positive:Negative)

NA

 

Stage

 1 / 2 or 3 / 4

1 / 5 / 24

30

 Recurrence-free survival time (months)

10.3 (0.23–223.49)

35

  1. PDTC/ATC Poorly-Differentiated Thyroid Cancer/Anaplastic Thyroid Cancer
  2. Data in parentheses are ranges